Suchergebnisse - Parallel Concurrent Pr

  1. 1

    Autoren: Lu Y Yang F Liu Y et al.

    Quelle: International journal of legal medicine [Int J Legal Med] 2025 Dec 18. Date of Electronic Publication: 2025 Dec 18.

    Publikationsart: Journal Article

    Info zur Zeitschrift: Publisher: Springer International Country of Publication: Germany NLM ID: 9101456 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-1596 (Electronic) Linking ISSN: 09379827 NLM ISO Abbreviation: Int J Legal Med Subsets: MEDLINE

  2. 2

    Autoren: Beltrame R

    Quelle: Methodologia online WP 327 (2018).
    info:cnr-pdr/source/autori:Beltrame R./titolo:Meccanismi del fluire di un'attività complessa in un approccio per processi concorrenti./doi:/rivista:Methodologia online/anno:2018/pagina_da:/pagina_a:/intervallo_pagine:/volume:WP 327

    Dateibeschreibung: application/pdf

  3. 3
  4. 4
  5. 5

    Autoren: Kaushik M Liew ZH Sewa DW et al.

    Körperschaften: Kaushik M Liew ZH Sewa DW et al.

    Quelle: Journal of clinical apheresis [J Clin Apher] 2021 Feb; Vol. 36 (1), pp. 211-218. Date of Electronic Publication: 2020 Nov 21.

    Publikationsart: Case Reports; Journal Article

    Info zur Zeitschrift: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8216305 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-1101 (Electronic) Linking ISSN: 07332459 NLM ISO Abbreviation: J Clin Apher Subsets: MEDLINE

  6. 6

    Quelle: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of MT10109L (NivobotulinumtoxinA) for the Treatment of Lateral Canthal Lines With or Without Concurrent Treatment of Glabellar Lines

  7. 7

    Autoren: Kurt Y Nolte T Luyten P et al.

    Körperschaften: Kurt Y Nolte T Luyten P et al.

    Quelle: Clinical psychology & psychotherapy [Clin Psychol Psychother] 2025 Nov-Dec; Vol. 32 (6), pp. e70185.

    Publikationsart: Journal Article

    Info zur Zeitschrift: Publisher: John Wiley & Sons Country of Publication: England NLM ID: 9416196 Publication Model: Print Cited Medium: Internet ISSN: 1099-0879 (Electronic) Linking ISSN: 10633995 NLM ISO Abbreviation: Clin Psychol Psychother Subsets: MEDLINE

  8. 8

    Quelle: A Randomized, Open Label, Parallel Controlled, Multicenter Phase Ib/II Clinical Trial to Evaluate the Efficacy and Safety of TQB3728 Tablets in Sequential Maintenance of TQB2450 Injection Therapy in Patients After Sequential or Concurrent Chemoradiation for Locally Advanced Non-small Cell Lung Cancer.

  9. 9

    Quelle: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of MT10109L (NivobotulinumtoxinA) for the Treatment of Glabellar Lines With or Without Concurrent Treatment of Lateral Canthal Lines

  10. 10
  11. 11

    Quelle: Therapeutic Efficacy and Safety of Concurrent FOLFIRINOX Plus HIFU for Locally Advanced/Borderline Resectable Pancreatic Cancer: A Prospective Single-center, Single-arm, Investigator-initiated, Open-labeled, Exploratory Clinical Trial
    Conroy T, Desseigne F, Ychou M, Bouche O, Guimbaud R, Becouarn Y, Adenis A, Raoul JL, Gourgou-Bourgade S, de la Fouchardiere C, Bennouna J, Bachet JB, Khemissa-Akouz F, Pere-Verge D, Delbaldo C, Assenat E, Chauffert B, Michel P, Montoto-Grillot C, Ducreux M; Groupe Tumeurs Digestives of Unicancer; PRODIGE Intergroup. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med. 2011 May 12;364(19):1817-25. doi: 10.1056/NEJMoa1011923.
    Conroy T, Hammel P, Hebbar M, Ben Abdelghani M, Wei AC, Raoul JL, Chone L, Francois E, Artru P, Biagi JJ, Lecomte T, Assenat E, Faroux R, Ychou M, Volet J, Sauvanet A, Breysacher G, Di Fiore F, Cripps C, Kavan P, Texereau P, Bouhier-Leporrier K, Khemissa-Akouz F, Legoux JL, Juzyna B, Gourgou S, O'Callaghan CJ, Jouffroy-Zeller C, Rat P, Malka D, Castan F, Bachet JB; Canadian Cancer Trials Group and the Unicancer-GI-PRODIGE Group. FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer. N Engl J Med. 2018 Dec 20;379(25):2395-2406. doi: 10.1056/NEJMoa1809775.
    Murphy JE, Wo JY, Ryan DP, Jiang W, Yeap BY, Drapek LC, Blaszkowsky LS, Kwak EL, Allen JN, Clark JW, Faris JE, Zhu AX, Goyal L, Lillemoe KD, DeLaney TF, Fernandez-Del Castillo C, Ferrone CR, Hong TS. Total Neoadjuvant Therapy With FOLFIRINOX Followed by Individualized Chemoradiotherapy for Borderline Resectable Pancreatic Adenocarcinoma: A Phase 2 Clinical Trial. JAMA Oncol. 2018 Jul 1;4(7):963-969. doi: 10.1001/jamaoncol.2018.0329.
    Choi YH, Lee SH, You MS, Shin BS, Paik WH, Ryu JK, Kim YT, Kwon W, Jang JY, Kim SW. Prognostic Factors for Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer Receiving Neoadjuvant FOLFIRINOX. Gut Liver. 2021 Mar 15;15(2):315-323. doi: 10.5009/gnl19182.
    Hackert T, Sachsenmaier M, Hinz U, Schneider L, Michalski CW, Springfeld C, Strobel O, Jager D, Ulrich A, Buchler MW. Locally Advanced Pancreatic Cancer: Neoadjuvant Therapy With Folfirinox Results in Resectability in 60% of the Patients. Ann Surg. 2016 Sep;264(3):457-63. doi: 10.1097/SLA.0000000000001850.
    Wu F, Wang ZB, Zhu H, Chen WZ, Zou JZ, Bai J, Li KQ, Jin CB, Xie FL, Su HB. Feasibility of US-guided high-intensity focused ultrasound treatment in patients with advanced pancreatic cancer: initial experience. Radiology. 2005 Sep;236(3):1034-40. doi: 10.1148/radiol.2362041105. Epub 2005 Jul 29.
    Vidal-Jove J, Perich E, Del Castillo MA. Ultrasound Guided High Intensity Focused Ultrasound for malignant tumors: The Spanish experience of survival advantage in stage III and IV pancreatic cancer. Ultrason Sonochem. 2015 Nov;27:703-706. doi: 10.1016/j.ultsonch.2015.05.026. Epub 2015 May 27.
    Marinova M, Huxold HC, Henseler J, Mucke M, Conrad R, Rolke R, Ahmadzadehfar H, Rauch M, Fimmers R, Luechters G, Cuhls H, Radbruch L, Schild HH, Strunk H. Clinical Effectiveness and Potential Survival Benefit of US-Guided High-Intensity Focused Ultrasound Therapy in Patients with Advanced-Stage Pancreatic Cancer. Ultraschall Med. 2019 Oct;40(5):625-637. doi: 10.1055/a-0591-3386. Epub 2018 Apr 17.
    Li T, Wang YN, Khokhlova TD, D'Andrea S, Starr F, Chen H, McCune JS, Risler LJ, Mashadi-Hossein A, Hingorani SR, Chang A, Hwang JH. Pulsed High-Intensity Focused Ultrasound Enhances Delivery of Doxorubicin in a Preclinical Model of Pancreatic Cancer. Cancer Res. 2015 Sep 15;75(18):3738-46. doi: 10.1158/0008-5472.CAN-15-0296. Epub 2015 Jul 27.
    Lee ES, Lee JY, Kim H, Choi Y, Park J, Han JK, Choi BI. Pulsed high-intensity focused ultrasound enhances apoptosis of pancreatic cancer xenograft with gemcitabine. Ultrasound Med Biol. 2013 Nov;39(11):1991-2000. doi: 10.1016/j.ultrasmedbio.2013.06.004. Epub 2013 Aug 22.
    Lee JY, Choi BI, Ryu JK, Kim YT, Hwang JH, Kim SH, Han JK. Concurrent chemotherapy and pulsed high-intensity focused ultrasound therapy for the treatment of unresectable pancreatic cancer: initial experiences. Korean J Radiol. 2011 Mar-Apr;12(2):176-86. doi: 10.3348/kjr.2011.12.2.176. Epub 2011 Mar 3.
    Rapoport N, Payne A, Dillon C, Shea J, Scaife C, Gupta R. Focused ultrasound-mediated drug delivery to pancreatic cancer in a mouse model. J Ther Ultrasound. 2013 Jul 1;1:11. doi: 10.1186/2050-5736-1-11. eCollection 2013.
    Park EJ, Ahn YD, Lee JY. In vivo study of enhanced chemotherapy combined with ultrasound image-guided focused ultrasound (USgFUS) treatment for pancreatic cancer in a xenograft mouse model. Eur Radiol. 2018 Sep;28(9):3710-3718. doi: 10.1007/s00330-018-5355-9. Epub 2018 Mar 29.
    Yu MH, Lee JY, Kim HR, Kim BR, Park EJ, Kim HS, Han JK, Choi BI. Therapeutic Effects of Microbubbles Added to Combined High-Intensity Focused Ultrasound and Chemotherapy in a Pancreatic Cancer Xenograft Model. Korean J Radiol. 2016 Sep-Oct;17(5):779-88. doi: 10.3348/kjr.2016.17.5.779. Epub 2016 Aug 23.
    Kim JH, Kim H, Kim YJ, Lee JY, Han JK, Choi BI. Dynamic contrast-enhanced ultrasonographic (DCE-US) assessment of the early response after combined gemcitabine and HIFU with low-power treatment for the mouse xenograft model of human pancreatic cancer. Eur Radiol. 2014 Sep;24(9):2059-68. doi: 10.1007/s00330-014-3260-4. Epub 2014 Jun 25.
    Yoo C, Lee SS, Song KB, Jeong JH, Hyung J, Park DH, Song TJ, Seo DW, Lee SK, Kim MH, Lee SS, Kim JH, Jin HS, Park JH, Hwang DW, Lee JH, Lee W, Chang HM, Kim KP, Ryoo BY, Kim SC. Neoadjuvant modified FOLFIRINOX followed by postoperative gemcitabine in borderline resectable pancreatic adenocarcinoma: a Phase 2 study for clinical and biomarker analysis. Br J Cancer. 2020 Aug;123(3):362-368. doi: 10.1038/s41416-020-0867-x. Epub 2020 May 20.
    Janssen QP, Buettner S, Suker M, Beumer BR, Addeo P, Bachellier P, Bahary N, Bekaii-Saab T, Bali MA, Besselink MG, Boone BA, Chau I, Clarke S, Dillhoff M, El-Rayes BF, Frakes JM, Grose D, Hosein PJ, Jamieson NB, Javed AA, Khan K, Kim KP, Kim SC, Kim SS, Ko AH, Lacy J, Margonis GA, McCarter MD, McKay CJ, Mellon EA, Moorcraft SY, Okada KI, Paniccia A, Parikh PJ, Peters NA, Rabl H, Samra J, Tinchon C, van Tienhoven G, van Veldhuisen E, Wang-Gillam A, Weiss MJ, Wilmink JW, Yamaue H, Homs MYV, van Eijck CHJ, Katz MHG, Groot Koerkamp B. Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis. J Natl Cancer Inst. 2019 Aug 1;111(8):782-794. doi: 10.1093/jnci/djz073.
    Suker M, Beumer BR, Sadot E, Marthey L, Faris JE, Mellon EA, El-Rayes BF, Wang-Gillam A, Lacy J, Hosein PJ, Moorcraft SY, Conroy T, Hohla F, Allen P, Taieb J, Hong TS, Shridhar R, Chau I, van Eijck CH, Koerkamp BG. FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis. Lancet Oncol. 2016 Jun;17(6):801-810. doi: 10.1016/S1470-2045(16)00172-8. Epub 2016 May 6.
    Rombouts SJ, Walma MS, Vogel JA, van Rijssen LB, Wilmink JW, Mohammad NH, van Santvoort HC, Molenaar IQ, Besselink MG. Systematic Review of Resection Rates and Clinical Outcomes After FOLFIRINOX-Based Treatment in Patients with Locally Advanced Pancreatic Cancer. Ann Surg Oncol. 2016 Dec;23(13):4352-4360. doi: 10.1245/s10434-016-5373-2. Epub 2016 Jul 1.

  12. 12
  13. 13

    Quelle: Mikrochimica acta [Mikrochim Acta] 2025 May 07; Vol. 192 (6), pp. 340. Date of Electronic Publication: 2025 May 07.

    Publikationsart: Journal Article

    Info zur Zeitschrift: Publisher: Springer-Verlag Country of Publication: Austria NLM ID: 7808782 Publication Model: Electronic Cited Medium: Internet ISSN: 1436-5073 (Electronic) Linking ISSN: 00263672 NLM ISO Abbreviation: Mikrochim Acta Subsets: MEDLINE

  14. 14

    Quelle: ISSN: 0021-9991.

    Schlagwörter: Probabilistic Domain Decomposition, Probabilistic representation of solution of partial differential equations, Quasi-Monte carlo, ACM: G.: Mathematics of Computing/G.4: MATHEMATICAL SOFTWARE/G.4.0: Algorithm design and analysis, ACM: G.: Mathematics of Computing/G.4: MATHEMATICAL SOFTWARE/G.4.3: Efficiency, ACM: G.: Mathematics of Computing/G.1: NUMERICAL ANALYSIS/G.1.1: Interpolation, ACM: G.: Mathematics of Computing/G.1: NUMERICAL ANALYSIS/G.1.8: Partial Differential Equations/G.1.8.0: Domain decomposition methods, ACM: G.: Mathematics of Computing/G.1: NUMERICAL ANALYSIS/G.1.8: Partial Differential Equations/G.1.8.5: Hyperbolic equations, ACM: G.: Mathematics of Computing/G.1: NUMERICAL ANALYSIS/G.1.8: Partial Differential Equations, ACM: G.: Mathematics of Computing/G.1: NUMERICAL ANALYSIS/G.1.1: Interpolation/G.1.1.4: Spline and piecewise polynomial interpolation, ACM: D.: Software/D.1: PROGRAMMING TECHNIQUES/D.1.3: Concurrent Programming/D.1.3.1: Parallel programming, ACM: D.: Software/D.2: SOFTWARE ENGINEERING/D.2.4: Software/Program Verification, ACM: D.: Software/D.2: SOFTWARE ENGINEERING/D.2.4: Software/Program Verification/D.2.4.7: Statistical methods, ACM: J.: Computer Applications, ACM: J.: Computer Applications/J.2: PHYSICAL SCIENCES AND ENGINEERING/J.2.8: Physics, ACM: G.: Mathematics of Computing/G.4: MATHEMATICAL SOFTWARE/G.4.4: Parallel and vector implementations, ACM: G.: Mathematics of Computing/G.4: MATHEMATICAL SOFTWARE/G.4.6: Reliability and robustness, ACM: G.: Mathematics of Computing/G.3: PROBABILITY AND STATISTICS, ACM: G.: Mathematics of Computing/G.3: PROBABILITY AND STATISTICS/G.3.7: Probabilistic algorithms (including Monte Carlo), ACM: G.: Mathematics of Computing/G.3: PROBABILITY AND STATISTICS/G.3.15: Stochastic processes, ACM: G.: Mathematics of Computing/G.2: DISCRETE MATHEMATICS/G.2.1: Combinatorics, ACM: G.: Mathematics of Computing/G.2: DISCRETE MATHEMATICS/G.2.1: Combinatorics/G.2.1.0: Combinatorial algorithms, ACM: G.: Mathematics of Computing/G.1: NUMERICAL ANALYSIS, [INFO.INFO-MO]Computer Science [cs]/Modeling and Simulation, [SPI.PLASMA]Engineering Sciences [physics]/Plasmas, [MATH.MATH-AP]Mathematics [math]/Analysis of PDEs [math.AP], [MATH.MATH-PR]Mathematics [math]/Probability [math.PR], [INFO.INFO-NA]Computer Science [cs]/Numerical Analysis [cs.NA], [INFO.INFO-DC]Computer Science [cs]/Distributed, Parallel

  15. 15

    Dateibeschreibung: application/pdf

    Relation: Symposium on Computer Architecture and High Performance Computing. Proceedings, 1550-6533; 2005; 17th Symposium on Computer Architecture and High Performance Computing : SBAC-PAD 2005 : proceedings : 24-27 October, 2005, Rio de Janeiro, PR, Brazil, p. 44-51; Local 2082/752

  16. 16

    Quelle: Cureus [Cureus] 2021 Dec 25; Vol. 13 (12), pp. e20691. Date of Electronic Publication: 2021 Dec 25 (Print Publication: 2021).

    Publikationsart: Journal Article

    Info zur Zeitschrift: Publisher: Cureus, Inc Country of Publication: United States NLM ID: 101596737 Publication Model: eCollection Cited Medium: Print ISSN: 2168-8184 (Print) Linking ISSN: 21688184 NLM ISO Abbreviation: Cureus Subsets: PubMed not MEDLINE

  17. 17

    Autoren: Dhanjal A Shaw JG Cole J et al.

    Quelle: AIDS (London, England) [AIDS] 2025 Dec 01; Vol. 39 (15), pp. 2151-2160. Date of Electronic Publication: 2025 Nov 13.

    Publikationsart: Journal Article; Review

    Info zur Zeitschrift: Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 8710219 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-5571 (Electronic) Linking ISSN: 02699370 NLM ISO Abbreviation: AIDS Subsets: MEDLINE

  18. 18
  19. 19
  20. 20